<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>SearchForVideo.com Cyclophosphamide RSS</title>
    <link>http://www.searchforvideo.com</link>
    <description>SearchForVideo.com Cyclophosphamide videos</description>
    <item>
      <title>India for Lymphoblastic leu...Picture Box by Healthcaretourismindia</title>
      <link>http://www.google.ca/url?q=http://healthcaretourismindia.picturepush.com/album/43079/2080085/Picture-Box/India-for-Lymphoblastic-leu....html&amp;source=video&amp;vgc=rss&amp;usg=AFQjCNGZ6T5JkN2Vx2lcWQMvsDZZ8vlDFg</link>
      <description>lymphoblastic lymphoma surgery is done with chemotherapy, including high-dose methotrexate (MTX), cytarabine, and cyclophosphamide. India is one ...  healthcaretourismindia.picturepush.com</description>
    </item>
    <item>
      <title>TAPPING NON-SELECTED LYMPHOCYTE POPULATIONS TO OBTAIN HIGH-AFFINITY TCR - CANCER</title>
      <link>http://youtube.com/?v=mtmaJpZvq0k</link>
      <description>Author:  WiKuMedia  
					Keywords:   wikumedia   wikumedi@   Immunsystem   Medizin   Immunology   Zink   Congress   Health   Ern&#195;&#164;hrung   Gesundheit   Immunity   Darmerkrankung   Vitamin   medicine   Inkt   cells   Homeostasis   Glycosphingolipid   skint1   TGF-&#195;&#376;   CD27   RORgt   interferon-&#206;&#177;   CD137   immunotherapy   Tumor   Leukemic   IL-21   lymphocytes   cytotoxic   immunosuppression   melanoma   hiv   aids   infection   antiviral   iris   NEOREACTIVITY   cancer   antigen   glycan   lymphocyte   high-affinity   ox40   immunotherapeutic   vaccine   cyclophosphamide   antitumor   immunogenicity   transgenic  
					Added: September 30, 2009</description>
    </item>
    <item>
      <title>OX40 INHIBITION OF TREG SUPPRESSION - IMMUNOTHERAPY OF CANCER - 2nd European Congress of Immunology</title>
      <link>http://youtube.com/?v=4TXK6PsN-ng</link>
      <description>Author:  WiKuMedia  
					Keywords:   wikumedia   wikumedi@   Immunsystem   Medizin   Immunology   Zink   Congress   Health   Ern&#195;&#164;hrung   Gesundheit   Immunity   Darmerkrankung   Vitamin   medicine   Inkt   cells   Homeostasis   Glycosphingolipid   skint1   TGF-&#195;&#376;   CD27   RORgt   interferon-&#206;&#177;   CD137   immunotherapy   Tumor   Leukemic   IL-21   lymphocytes   cytotoxic   immunosuppression   melanoma   hiv   aids   infection   antiviral   iris   NEOREACTIVITY   cancer   antigen   glycan   lymphocyte   high-affinity   ox40   immunotherapeutic   vaccine   cyclophosphamide   antitumor   immunogenicity   transgenic  
					Added: September 30, 2009</description>
    </item>
    <item>
      <title>REMODELING TUMOR VASCULATURE: A NEW APPROACH TO THERAPY - IMMUNOTHERAPY OF CANCER</title>
      <link>http://youtube.com/?v=GmxdBlA_8kk</link>
      <description>Author:  WiKuMedia  
					Keywords:   wikumedia   wikumedi@   Immunsystem   Medizin   Immunology   Zink   Congress   Health   Ern&#195;&#164;hrung   Gesundheit   Immunity   Darmerkrankung   Vitamin   medicine   Inkt   cells   Homeostasis   Glycosphingolipid   skint1   TGF-&#195;&#376;   CD27   RORgt   interferon-&#206;&#177;   CD137   immunotherapy   Tumor   Leukemic   IL-21   lymphocytes   cytotoxic   immunosuppression   melanoma   hiv   aids   infection   antiviral   iris   NEOREACTIVITY   cancer   antigen   glycan   lymphocyte   high-affinity   ox40   immunotherapeutic   vaccine   cyclophosphamide   antitumor   immunogenicity   transgenic  
					Added: September 30, 2009</description>
    </item>
    <item>
      <title>REGULATORY T CELLS IN CANCER AND THEIR SUPPRESSION AS A STRATEGY TO ENHANCE THE EFFICACY - CANCER</title>
      <link>http://youtube.com/?v=dBiLZXyxhp4</link>
      <description>Author:  WiKuMedia  
					Keywords:   wikumedia   wikumedi@   Immunsystem   Medizin   Immunology   Zink   Congress   Health   Ern&#195;&#164;hrung   Gesundheit   Immunity   Darmerkrankung   Vitamin   medicine   Inkt   cells   Homeostasis   Glycosphingolipid   skint1   TGF-&#195;&#376;   CD27   RORgt   interferon-&#206;&#177;   CD137   immunotherapy   Tumor   Leukemic   IL-21   lymphocytes   cytotoxic   immunosuppression   melanoma   hiv   aids   infection   antiviral   iris   NEOREACTIVITY   cancer   antigen   glycan   lymphocyte   high-affinity   ox40   immunotherapeutic   vaccine   cyclophosphamide   antitumor   immunogenicity   transgenic  
					Added: September 30, 2009</description>
    </item>
    <item>
      <title>LOW-DOSE CYCLOPHOSPHAMIDE TREATMENT AUGMENTS ANTITUMOR IMMUNE RESPONSES - IMMUNOTHERAPY OF CANCER</title>
      <link>http://youtube.com/?v=c3Uqy6_ifls</link>
      <description>Author:  WiKuMedia  
					Keywords:   wikumedia   wikumedi@   Immunsystem   Medizin   Immunology   Zink   Congress   Health   Ern&#195;&#164;hrung   Gesundheit   Immunity   Darmerkrankung   Vitamin   medicine   Inkt   cells   Homeostasis   Glycosphingolipid   skint1   TGF-&#195;&#376;   CD27   RORgt   interferon-&#206;&#177;   CD137   immunotherapy   Tumor   Leukemic   IL-21   lymphocytes   cytotoxic   immunosuppression   melanoma   hiv   aids   infection   antiviral   iris   NEOREACTIVITY   cancer   antigen   glycan   lymphocyte   high-affinity   ox40   immunotherapeutic   vaccine   cyclophosphamide   antitumor   immunogenicity   transgenic  
					Added: September 30, 2009</description>
    </item>
    <item>
      <title>Getting off the Ground</title>
      <link>http://youtube.com/?v=_Rk4FN1wHG0</link>
      <description>Author:  JohnsHopkins  
					Keywords:   Johns Hopkins University   Johns Hopkins Hospital   cyclophosphamide   HiCy clinical trial   Robert Brodsky   Alvin Myerberg   autoimmune disorders   multiple sclerosis (MS  
					Added: November 2, 2009</description>
    </item>
    <item>
      <title>antimitotique chimiotherapie</title>
      <link>http://www.google.ca/url?q=http://www.dailymotion.com/video/x6nvdt_antimitotique-chimiotherapie_tech&amp;source=video&amp;vgc=rss&amp;usg=AFQjCNGVKJbDjJhLXP4mKC-HOL3m8xr3qA</link>
      <description>500mg Bleomycine 15mg cisplatine 10mg 25mg 50mg Vinblastine 10mg Cyclophosphamide 50mg 100mg 200mg 500mg Melphalan 2mg Rituximab 100mg 500mg ...  dailymotion.com</description>
    </item>
    <item>
      <title>Fda Approves Two New Indications For Rituxan...</title>
      <link>http://www.google.ca/url?q=http://www.metacafe.com/watch/289667/fda_approves_two_new_indications_for_rituxan/&amp;source=video&amp;vgc=rss&amp;usg=AFQjCNFrnFfHHz_ij1voasiMsEavkYBwig</link>
      <description>previously untreated patients with follicular NHL in combination with CVP (cyclophosphamide, vincristine and prednisolone) chemotherapy. The ...  metacafe.com</description>
    </item>
    <item>
      <title>Hunter's Last Dose!</title>
      <link>http://www.google.ca/url?q=http://www.youtube.com/watch%3Fv%3DXk8VxLeBLWw&amp;source=video&amp;vgc=rss&amp;usg=AFQjCNERU6mSJc1KyqncyBpca1R7DyOOlw</link>
      <description>Hunter getting his last dose of Cyclophosphamide chemo at Doernbechers Children&amp;#39;s Hospital!!!!! YAY....conditioning for transplant is almost ...  youtube.com</description>
    </item>
    <item>
      <title>LOW-DOSE  TREATMENT AUGMENTS ANTITUMOR IMMUNE RESPONSES - IMMUNOTHERAPY OF CANCER</title>
      <link>http://www.google.ca/url?q=http://www.youtube.com/watch%3Fv%3Dc3Uqy6_ifls&amp;source=video&amp;vgc=rss&amp;usg=AFQjCNHrZm1f8i4kGYRe2aZDrz-BMODXPA</link>
      <description>The 2nd European Congress of Immunology - Immunity for Life, Immunology for Health -- IMMUNOTHERAPY OF CANCER - LOW-DOSE CYCLOPHOSPHAMIDE ...  youtube.com</description>
    </item>
    <item>
      <title>High Dose  (HiCy) in Multiple Sclerosis</title>
      <link>http://www.google.ca/url?q=http://video.google.com/videoplay%3Fdocid%3D-7875556960908357407&amp;source=video&amp;vgc=rss&amp;usg=AFQjCNFA5fNsBH_EjRPLwseNHwg2Dr2t_w</link>
      <description>2008 Rare Neuroimmunologic Disorders Symposium, High Dose Cyclophosphamide in Multiple Sclerosis, Chitra Krishnan, MHS, Adam I. Kaplin, MD, PhD  video.google.com</description>
    </item>
    <item>
      <title>Acute Therapies: Steroids, IVIG, Plasmaexchange and </title>
      <link>http://www.google.ca/url?q=http://video.google.com/videoplay%3Fdocid%3D-6520984212253897481&amp;source=video&amp;vgc=rss&amp;usg=AFQjCNF90d3XN3wETXsXX57UBT5L-8Ebow</link>
      <description>2008 Rare Neuroimmunologic Disorders Symposium, Acute Therapies: Steroids, IVIG, Plasmaexchange and Cyclophosphamide, Benjamin M. Greenberg, MD, MHS  video.google.com</description>
    </item>
    <item>
      <title>Acute Therapies</title>
      <link>http://xml.truveo.com/rd?i=4108881018&amp;a=rss&amp;p=7&amp;h=4b37107cd66b68:7a48f11701dee6fd421bfeb0292ad8fa</link>
      <description>2004 Rare Neuroimmunologic Disorders Symposium Acute Therapies B. Weinshenker, MD Corticosteroids, Plasma Exchange, Cyclophosphamide</description>
    </item>
    <item>
      <title>High Dose Cyclophosphamide (HiCy) in Multiple Sclerosis</title>
      <link>http://xml.truveo.com/rd?i=503021264&amp;a=rss&amp;p=8&amp;h=4b37107cd66b68:7a48f11701dee6fd421bfeb0292ad8fa</link>
      <description>2008 Rare Neuroimmunologic Disorders Symposium,  High Dose Cyclophosphamide in Multiple Sclerosis, Chitra Krishnan, MHS, Adam I. Kaplin, MD, PhD</description>
    </item>
    <item>
      <title>Hunter&#8217;s Last Dose!</title>
      <link>http://xml.truveo.com/rd?i=4107910167&amp;a=rss&amp;p=6&amp;h=4b37107cd66b68:7a48f11701dee6fd421bfeb0292ad8fa</link>
      <description>Hunter getting his last dose of Cyclophosphamide chemo at Doernbechers Children&#226;&#8364;&#8482;s Hospital!!!!! YAY....conditioning for transplant is almost complete!!! www.healinghunter.com</description>
    </item>
    <item>
      <title>Rituximab may reduce inflammation in severe lupus nephritis</title>
      <link>http://xml.truveo.com/rd?i=4139219895&amp;a=rss&amp;p=4&amp;h=4b37107cd66b68:7a48f11701dee6fd421bfeb0292ad8fa</link>
      <description>NEW YORK (Reuters Health) - Rituximab appears to be of benefit to some patients with severe proliferative or membranous lupus nephritis,  according to a small French study published in online by the Clinical Journal of the American Society of Nephrology.&amp;#32;&amp;#32;\u201cStandard treatment for lupus nephritis, including corticosteroids and cyclophosphamide, is efficient but is still associated with refractory or relapsing disease, or severe deleterious effects,\u201d note Dr. Fadi Fakhouri at Imperial College London, UK, and co-authors in France.  Because hyperreactive B cells are involved in the pathogenesis of SLE, the authors theorized that rituximab, a monoclonal anti-B cell antibody, would improve outcomes of severe lupus nephritis.  Previous reports on this topic included patients with less severe kidney disease followed for short periods of time.  The 20 patients (ages 17-37) in their series had class IV or V lupus nephritis despite the fact that 18 patients had undergone high-dose immunosuppressive therapy.  Eighteen patients had nephrotic syndrome and nine had acute renal insufficiency.  Rituximab was administered weekly for 4 weeks at 375 mg\/m\u00b2.  Ten patients received the drug as a maintenance therapy following B cell rebound.  After median follow-up of 22 months (range 10-51 months), seven patients experienced a complete renal remission and five had a partial remission.  Renal response occurred in less than 6 months in 6 patients, at 12 months in 5, and at 26 months in 1.  \u201cSixty percent response in severe lupus nephritis seems quite promising,\u201d the team writes.  Extrarenal benefits were observed as well, including resolution of hematologic disorders in 6 of 12 patients and reductions in corticosteroid dosages.  There was a strong association between B cell depletion at month 1 and treatment success.  Overall, renal remission occurred in 92% of those with B cell depletion.  None of the three patients with rapidly progressive glomeruloneph...</description>
    </item>
    <item>
      <title>LOW-DOSE CYCLOPHOSPHAMIDE TREATMENT AUGMENTS ANTITUMOR IMMUNE RESPONSES</title>
      <link>http://xml.truveo.com/rd?i=1538884378&amp;a=rss&amp;p=2&amp;h=4b37107cd66b68:7a48f11701dee6fd421bfeb0292ad8fa</link>
      <description>Immunity for Life,  Immunology for Health &amp;#8212; IMMUNOTHERAPY OF CANCER - LOW-DOSE CYCLOPHOSPHAMIDE TREATMENT AUGMENTS ANTITUMOR IMMUNE RESPONSES AND TUMOR IMMUNOGENICITY IN RET TRANSGENIC MOUSE MELANOMA MODEL - Speaker: A. Sevko - ICC Berlin - 16.09.2009 ... wikumedia wikumedi@ Immunsystem Medizin Immunology Zink Congress Health Ern&#195;&#164;hrung Gesundheit Immunity Darmerkrankung Vitamin medicine Inkt cells Homeostasis Glycosphingolipid skint1 TGF-&#195;&#376; CD27 RORgt interferon-&#206;&#177; CD137 immunotherapy Tumor ...</description>
    </item>
    <item>
      <title>High-Dose Cyclophosphamide: a cure for autoimmune disease?</title>
      <link>http://youtube.com/?v=QoWXnXgDpSQ</link>
      <description>Author:  ChrisHadMS  
					Keywords:   multiple   sclerosis   ms   hicy   high   dose   cyclophosphamide   cytoxan   revimmune   johns   hopkins   autoimmune   disease   cure  
					Added: July 16, 2008</description>
    </item>
    <item>
      <title>Immunotherapy for Prostate Cancer</title>
      <link>http://youtube.com/?v=gmaqBcoLgjk</link>
      <description>Author:  riemenschneider2  
					Keywords:   Immunotherapy   Prostate   Cancer   Rimenschneider   cryo   cryotherapy   cyclophosphamide   t-cells   psa   gleason   frequency   incontinence   impotence   cancer   cure   nocturia   hematuria   lupron   galil   vantas   endocare   duke   bahn   hogdon   radge   aaron   katz   gary   onik   jeffrey   cohen   cytoxan   pcri  
					Added: November 29, 2008</description>
    </item>
    <item>
      <title>IN-VIVO DENDRITIC CELL TARGETING USING GLYCAN MODIFIED ANTIGEN - IMMUNOTHERAPY OF CANCER</title>
      <link>http://youtube.com/?v=OkYMclGnDFU</link>
      <description>Author:  WiKuMedia  
					Keywords:   wikumedia   wikumedi@   Immunsystem   Medizin   Immunology   Zink   Congress   Health   Ern&#195;&#164;hrung   Gesundheit   Immunity   Darmerkrankung   Vitamin   medicine   Inkt   cells   Homeostasis   Glycosphingolipid   skint1   TGF-&#195;&#376;   CD27   RORgt   interferon-&#206;&#177;   CD137   immunotherapy   Tumor   Leukemic   IL-21   lymphocytes   cytotoxic   immunosuppression   melanoma   hiv   aids   infection   antiviral   iris   NEOREACTIVITY   cancer   antigen   glycan   lymphocyte   high-affinity   ox40   immunotherapeutic   vaccine   cyclophosphamide   antitumor   immunogenicity   transgenic  
					Added: September 30, 2009</description>
    </item>
    <item>
      <title>&#22899;&#20154;&#32633;&#24739;~~~~&#30284;&#30151;~~~&#26032;&#34277;~~~&#21487; </title>
      <link>http://www.google.ca/url?q=http://www.youtube.com/watch%3Fv%3DFJdG2tz1Vw8&amp;source=video&amp;vgc=rss&amp;usg=AFQjCNEL4hcXUwNX1XkMprnIZQJ2Cj0rGQ</link>
      <description>arthritis, can treat severe ANCA-associated vasculitis as effectively as cyclophosphamide, the current standard therapy. The news will be ...  youtube.com</description>
    </item>
    <item>
      <title>&#22899;&#20154;&#32633;&#24739;~~~~&#30284;&#30151;~~~&#26032;&#34277;~~~&#21487;&#20445;~~~&#29983;&#32946;&#21147;</title>
      <link>http://xml.truveo.com/rd?i=1353638227&amp;a=rss&amp;p=9&amp;h=4b3a710533c4e18:b78e20b598b4bab86b27ed0281f8676d</link>
      <description>top of your life-threatening disease by using cyclophosphamide,  there is the potential for major side effects down the road from this drug,'" said Robert Spiera, MD, an associate attending rheumatologist at Hospital for Special Surgery in New York. "This study provides strong evidence that Rituxan works as well as cyclophosphamide, at least in terms of getting patients into remission, and over that acute hump of being very ill. And, we can treat patients without the likelihood of ...</description>
    </item>
    <item>
      <title>What Are The Drugs, Timetable And Possible Side Effects Expected With The TAC Chemotherapy </title>
      <link>http://www.google.ca/url?q=http://abcnews.go.com/Health/OnCallPlusTreatment/drugs-timetable-side-effects-expected-tac-chemotherapy-protocol/story%3Fid%3D3751678&amp;source=video&amp;vgc=rss&amp;usg=AFQjCNHAlpm-RrnXXv68MWqC_DIlLtoTcg</link>
      <description>TAC is doxorubicin and docetaxel and cyclophosphamide, and this is a widely used regimen which replaced an older regimen called FAC. It was ...  abcnews.go.com</description>
    </item>
    <item>
      <title>India for Lymphoblastic leu... - Picture Box by Healthcaretourismindia - PicturePush</title>
      <link>http://www.google.ca/url?q=http://healthcaretourismindia.picturepush.com/album/43079/2080085/Picture-Box/India-for-Lymphoblastic-leu....html&amp;source=video&amp;vgc=rss&amp;usg=AFQjCNGZ6T5JkN2Vx2lcWQMvsDZZ8vlDFg</link>
      <description>lymphoblastic lymphoma surgery is done with chemotherapy, including high-dose methotrexate (MTX), cytarabine, and cyclophosphamide. India is one ...  healthcaretourismindia.picturepush.com</description>
    </item>
    <item>
      <title>Wegener Granulomatosis</title>
      <link>http://youtube.com/?v=_MeqZkym-M4</link>
      <description>Author:  USMLEVideoLectures  
					Keywords:   wegener   granulomatosis   ANCA   USMLE   steroids   cyclophosphamide  
					Added: January 15, 2010</description>
    </item>
    <item>
      <title>Fda Approves Herceptin&#174; for the Adjuvant Treatment of Her2-Posi</title>
      <link>http://www.metacafe.com/watch/334528/fda_approves_herceptin_for_the_adjuvant_treatment_of_her2_posi/</link>
      <description>-- HERCEPTIN REDUCED THE RISK OF BREAST CANCER RECURRENCE
BY 52 PERCENT IN PIVOTAL STUDIES --

-- ONLY TARGETED BIOLOGIC THERAPY APPROVED FOR USE IN ADJUVANT AND METASTATIC HER2-POSITIVE BREAST CANCER --

Genentech, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Herceptin (Trastuzumab) for the adjuvant treatment of HER2-positive node-positive breast cancer, as part of a treatment regimen containing doxorubicin, cyclophosphamide, and paclitaxel. The FDA approval was based on data from an interim joint analysis of more than 3,500 patients enrolled in two Phase III clinical trials.  These results showed that the addition of Herceptin to standard adjuvant therapy significantly reduced the risk of breast cancer recurrence, the primary endpoint of the studies, by 52 percent in women with HER2-positive breast cancer, compared to those patients who received standard adjuvant therapy alone.

Adjuvant therapy is given to women with early-stage (localized) breast cancer who have had initial treatment surgery with or without radiation therapy with the goal of reducing the risk of cancer recurrence and/or the occurrence of metastatic disease.					 Ranked  3.23  / 5 | 1191 views |  0 comments  
					 
					 
						  Click here to watch the video   (03:56) 
						Submitted By: 						 MultiVu  
						Tags:
						 Fda.approves &amp;nbsp; Herceptin &amp;nbsp; Adjuvant &amp;nbsp; Treatments &amp;nbsp; Node &amp;nbsp; Positive &amp;nbsp; Breasts &amp;nbsp; Cancer &amp;nbsp; Medicine &amp;nbsp; Illness &amp;nbsp; Documentaries &amp;nbsp;						 
						Categories:  News &amp;amp; Events</description>
    </item>
    <item>
      <title>Acute Therapies: Steroids,  IVIG, Plasmaexchange and Cyclophosphamide</title>
      <link>http://xml.truveo.com/rd?i=3815825754&amp;a=rss&amp;p=8&amp;h=4b5a0e7027109c4:323352a65ce5624be3042fa465e1d82b</link>
      <description>2008 Rare...</description>
    </item>
    <item>
      <title>What Are The Drugs, Timetable And Possible Side Effects Expected With The CEF Chemotherapy </title>
      <link>http://www.google.ca/url?q=http://abcnews.go.com/Health/OnCallPlusTreatment/drugs-timetable-side-effects-expected-cef-chemotherapy-protocol/story%3Fid%3D3751665&amp;source=video&amp;vgc=rss&amp;usg=AFQjCNHcDzSqy3zkJk2vWyAe1quHjXh_cQ</link>
      <description>CEF is cyclophosphamide, epirubicin, and 5-Fluorouracil (5-FU); it&amp;#39;s a popular regimen in some parts of the world. Epirubicin is a cousin of ...  abcnews.go.com</description>
    </item>
  </channel>
</rss>
